Shandong Wohua Pharmaceutical Technology Co., Ltd. (hereinafter referred to as the "Company") and all members of the Board of Directors guarantee that the information disclosed is true, accurate, and complete, without any false records, misleading statements, or significant omissions.
The 2025 annual equity distribution plan of the Company was approved at the 2025 Annual General Meeting held on February 9, 2026. The details of the equity distribution are as follows: